Dr Reddy’s to ring closing bell at NYSE to mark 25 years of its listing

Hyderabad: Pharma major Dr Reddy’s Laboratories Ltd on Thursday said it has been invited to ring the closing bell at the New York Stock Exchange (NYSE) to mark 25 years of its listing on the stock exchange. Dr Reddy’s became the first pharmaceutical company in Asia, outside Japan, to be listed on the NYSE in April 2001.

The Hyderabad-based company’s senior management team, including chairman Satish Reddy, CEO Erez Israeli, CFO MV Narasimham, along with its North America CEO Milan Kalawadia, global generics CEO MV Ramana as well as company secretary and CSR head K Randhir Singh, among others, will be attending the ceremony at NYSE in the wee hours of May 30 (IST).

Commenting on the development, Satish Reddy said: “Twenty-five years on the NYSE is more than a listing anniversary; it is a reaffirmation of our commitment to global governance, transparency and innovation.”

“When Dr K Anji Reddy founded this company, his vision was simple but powerful: bring affordable, innovative medicines to patients everywhere. That vision drove our NYSE debut in 2001 and continues to shape who we are today, a trusted name in the U.S. market, backed by differentiated products and consistent operations,” he added.